刘诺,王真真,陈乃宏
出版日期:
2017-10-26发布日期:
2017-12-01通讯作者:
陈乃宏,男,博士,教授;研究方向:神经药理学;Tel:+86-010-63165177,E-mail:chennh@imm.ac.cn作者简介:
刘诺,男,硕士;研究方向:神经药理学基金资助:
LIU Nuo,WANG Zhen-zhen,CHEN Nai-hong
Online:
2017-10-26Published:
2017-12-01Contact:
陈乃宏,男,博士,教授;研究方向:神经药理学;Tel:+86-010-63165177,E-mail:chennh@imm.ac.cnAbout author:
刘诺,男,硕士;研究方向:神经药理学Supported by:
摘要:
随着人口老龄化程度的加重,阿尔茨海默病(Alzheimer’s disease,AD)的发病率不断上升,然而目前该病的对因治理仍未取得突破。近年来,肠道菌群在AD 发病进程中发挥的作用日益受到关注,肠道菌群的种类和比例随着年龄增加会发生变化,其代谢产物数量改变对认知行为有一定影响,肠道菌群还与脑肠轴双向交流、相互作用。目前,已经证实肠道细菌参与到包括Aβ蛋白沉积、tau 蛋白过度磷酸化、神经炎症、氧化应激损伤、血脑屏障通透性增加、神经递质失平衡、胰岛素抵抗在内的AD 发病机制中。未来,针对致病相关种类的肠道细菌进行特异性调节将是重要的研究方向。
中图分类号:
刘诺,王真真,陈乃宏.肠道菌群在阿尔茨海默病发病中的作用[J]. 神经药理学报,DOI: 10.3969/j.issn.2095-1396.2017.05.005.
LIU Nuo,WANG Zhen-zhen,CHEN Nai-hong.The Role of Gut Flora in the Pathogenesis of Alzheimer’s Disease[J]. Acta Neuropharmacologica,DOI: 10.3969/j.issn.2095-1396.2017.05.005.
1William E Reichman, Nathan S Rose.History andexperience: the direction of Alzheimer's disease[J]. Menopause, 2012, 19(7): 724-734.
2Adele Costabile, Eddie R Deaville, Agustin Martin Morales,et al.Prebiotic potential of a maize-based soluble fibre and impact of dose on the human gut microbiota[J]. PloS one, 2016, 11(1): e0144457.
3James M Hill, Walter J Lukiw.Microbial-generated amyloids and Alzheimer's disease (AD)[J]. Frontiers in Aging Neuroscience, 2015, 7: 9.
4Surjyadipta Bhattacharjee, Walter J Lukiw.Alzheimer's disease and the microbiome[J]. Frontiers in Cellular Neuroscience, 2013, 7: 153.
5Masami Minemura, Yukihiro Shimizu.Gut microbiota and liver diseases[J]. J WorldGastroenterology, 2015, 21(6): 1691-1702.
6Kiyofumi Yamada, Toshitaka Nabeshima.Interaction ofBDNF/TrkB signaling with NMDA receptor in learning and memory[J]. Drug News Perspect,2004, 17(7): 435-438.
7Premysl Bercik, Emmanuel Denou, Josh Collins,et al.The intestinal microbiota affect central levels of brain-derived neurotropic factor and behavior in mice[J]. Gastroenterology, 2011, 141(2): 599-609. e3.
8Liang S, Wang T, Hu X,et al.Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress[J]. Neuroscience, 2015, 310: 561-577.
9Bhattacharjee S, Lukiw WJ. Alzheimer's disease and the microbiome. Frontiers in cellular neuroscience 7: 153 ;Matsumoto M, Benno Y (2004) Consumption of Bifidobacterium lactis LKM512 yogurt reduces gut mutagenicity by increasing gut polyamine contents in healthy adult subjects[J]. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 568: 147-153,
10Salazar N, López P, Valdés Let al.Microbial targets for the development of functional foods accordingly with nutritional and immune parameters altered in the elderly[J]. J American College of Nutrition, 2013, 32(6): 399-406.
11Marcus J Claesson, Siobhan Cusack, Orla O'Sullivan,et al.Composition, variability, and temporal stability of the intestinal microbiota of the elderly[J]. Proceedings of the National Academy of Sciences, 2011, 108(suppl1): 4586-4591.
12Claesson M J, Jeffery I B, Conde S,et al.Gut microbiota composition correlates with diet and health in the elderly[J]. Nature, 2012, 488(7410): 178.
13Odamaki T, Kato K, Sugahara H,et al.Age-related changes in gut microbiota composition from newborn to centenarian: a cross-sectional study[J]. BMC Microbiology, 2016, 16: 90.
14Augusto J Montiel-Castro, Rina M González-Cervantes, Gabriela Bravo-Ruiseco,et al.The microbiota-gut-brain axis: neurobehavioral correlates, health and sociality[J]. Frontiers in Integrative Neuroscience, 2013, 7: 70.
15Yunes R A, Poluektova E U, Dyachkova M S,et al.GABA production and structure of gadB/gadC genes in Lactobacillus and Bifidobacterium strains from human microbiota[J]. Anaerobe, 2016, 42: 197-204.
16Sun Yun-dong, Zhang Min, Chen Chun-chia,et al.Stress-induced corticotropin-releasing hormone-mediated NLRP6 inflammasome inhibition and transmissible enteritis in mice[J]. Gastroenterology, 2013, 144(7): 1478-1487. e8.
17O'Mahony S M, Marchesi J R, Scully P,et al. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses[J]. Biological Psychiatry, 2009, 65: 263-267.
18Zhao Yu-hai, Walter Lukiw.Microbiome-generated amyloid and potential impact on amyloidogenesis in Alzheimer’s disease (AD)[J]. J Nature and Science, 2015, 1(7), pii: e138:
19Rashid Deane, Shi Du Yan, Ram Kumar Submamaryan,et al.RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain[J]. Nature Medicine, 2003, 9: 907-913.
20Abdel-Latif M A, Ali H, Elbestawy A R,et al.Exogenous dietary lysozyme improves the growth performance and gut microbiota inbroiler chickens targeting the antioxidant and non-specific immunity mRNA expression[J]. PloS One, 2017, 12(10): e0185153.
21Rashid Deane, Wu Zhen-hua, Abhay Sagare,et al.LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms[J]. Neuron, 2004, 43(3): 333-344.
22Nicolas Weiss, Florence Miller, Sylvie Cazaubon,et al.The blood-brain barrier in brain homeostasis and neurological diseases[J]. Biochimica et Biophysica Acta , 2009, 1788(4): 842-857.
23James M Hill, Walter J Lukiw.Microbial-generatedamyloids and Alzheimer's disease (AD)[J]. Frontiers in aging neuroscience , 2015, 7: 9.
24Keshava Abbayya, Nagraj Y Puthanakar, Sanjay Naduwinmani,et al.Association between periodontitis and Alzheimer's disease[J]. North American J Medical Sciences, 2015, 7(6): 241.
25Rebecca Wall, John F Cryan, R Paul Ross,et al.Bacterial neuroactive compounds produced by psychobiotics. Microbial endocrinology: The microbiota-gut-brain axis in health and disease[J]. Advances in Experimental Medicine & Biology, 2014, 817(817):221.
26Yan Ming-hui, Han Jin, Xu Xiao-fen,et al.Gsy, a novel glucansucrase from Leuconostoc mesenteroides, mediates the formation of cell aggregates in response to oxidative stress[J]. Scientific Reports, 2016, 6: 38122.
27Helene M Savignac, Yvonne Couch, Michael Stratford,et al.Prebiotic administration normalizes lipopolysaccharide (LPS)-induced anxiety and cortical 5-HT2A receptor and IL1-β levels in male mice[J]. Brain, Behavior, and Immunity, 2016, 52: 120-131.
28Lehnardt S .Innate immunity and neuroinflammation in the CNS: The role of microglia in Toll‐like receptor‐mediated neuronal injury[J]. Glia, 2010, 58(3): 253-263.
29Patrice D Cani, Rodrigo Bibiloni, Claude Knauf,et al.Changes ingut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet–induced obesity and diabetes in mice[J]. Diabetes, 2008, 57(6): 1470-1481.
30Zhao Yu-hai, Vivian Jaber, Walter J Lukiw.Secretory Products of the Human GI Tract Microbiome and Their Potential Impact on Alzheimer's Disease (AD): Detection of Lipopolysaccharide (LPS) in AD Hippocampus[J]. Frontiers in Cellular and Infection Microbiology, 2017, 7: 318.
31Sandra Anne Banack, Tracie A Caller, Elijah W Stommel.The cyanobacteria derived toxin beta-N-methylamino-L-alanine and amyotrophic lateral sclerosis[J]. Toxins, 2010, 2: 2837-2850.
32Brenner S R. Blue-green algae or cyanobacteria in the intestinal micro-flora may produce neurotoxins such as Beta-N-Methylamino-L-Alanine (BMAA) which may be related to development of amyotrophic lateral sclerosis, Alzheimer's disease and Parkinson-Dementia-Complex in humans and Equine Motor Neuron Disease in horses[J]. Medical Hypotheses, 2013, 80: 103.
33Marnie Potgieter, Janette Bester, Douglas B Kell,et al.The dormant blood microbiome in chronic, inflammatory diseases[J]. FEMS Microbiology Reviews, 2015, 39(4): 567-591.
34雷曦,王健辉,程肖蕊等.基于快速老化模型小鼠SAMP8的CA-30抗阿尔茨海默病的作用研究[J].神经药理学报, 2018, 8(02): 44-45.
35Dalleau S, Baradat M, Gueraud F,et al.Cell death and diseases related tooxidative stress: 4-hydroxynonenal (HNE) in the balance[J]. Cell Death and Differentiation, 2013, 20: 1615.
36Lap Ho, Qin Wei-ping, Patrick N Pompl,et al.Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse modelof Alzheimer’s disease[J]. The FASEBJ, 2004, 18(7): 902-904.
37Pjotr Bekkering, Ismael Jafri, Frans Van Overveld,et al.The intricate association between gut microbiota and development of type 1, type 2 and type 3 diabetes[J]. Expert Review of Clinical Immunology, 2013, 9(11): 1031-1041.
38I Naseer M, Fehmida Bibi, Mohammed Al-Qahtani,et al.Role of gut microbiota in obesity, type 2 diabetes and Alzheimer’s disease[J]. CNS & Neurological Disorders-Drug Targets, 2014, 13(2): 305-311.
39Masami Minemura, Yukihiro Shimizu.Gut microbiota and liver diseases[J]. World J Gastroenterology, 2015, 21(6): 1691-1702.
40Leo Galland.The gut microbiome and the brain[J]. J Medicinal Food, 2014, 17(12): 1261-1272.
41Anni Woting, Michael Blaut.The intestinal microbiota in metabolic disease[J]. Nutrients, 2016, 8(4): 202.
|
[1] | 杨琳,艾静.脑源雌激素在阿尔茨海默病中的作用研究进展[J]. 神经药理学报, 2019, 9(5): 50-64. |
[2] | 张帅,艾静.谷氨酸功能异常与阿尔茨海默病[J]. 神经药理学报, 2018, 8(6): 9-20. |
[3] | SHEN li-xia1,LIU Liang-liang1,ZHANG Ming1,LIU Yang1,ZHANG Dan-shen 2*.Research of Quercetin’s Estrogen-Like Action on Central Nervous System and Its Mechanisms[J]. 神经药理学报, 2018, 8(4): 23-25. |
[4] | 黄蕊,杨翠翠,张兰.二苯乙烯苷对APP/PS1 双转基因小鼠学习记忆及突触可塑性的影响[J]. 神经药理学报, 2018, 8(2): 31-31. |
[5] | 雷曦,王健辉,程肖蕊,张小锐,刘港,周文霞,张永祥.基于快速老化模型小鼠SAMP8 的CA-30 抗阿尔茨海默病的作用研究[J]. 神经药理学报, 2018, 8(2): 50-50. |
[6] | 王健辉,程肖蕊,张小锐,刘港,周文霞,张永祥.药物组合吲哚美辛与阿托伐他汀对阿尔茨海默病的治疗作用研究[J]. 神经药理学报, 2018, 8(2): 52-52. |
[7] | 王静,程肖蕊,周文霞,张永祥.快速老化模型小鼠海马囊泡谷氨酸转运体表达与兴奋性毒性关系的研究[J]. 神经药理学报, 2018, 8(2): 53-53. |
[8] | 张林,蒋宁,周文霞,张永祥.疾病特异性诱导性多功能干细胞AD 模型建立[J]. 神经药理学报, 2018, 8(2): 54-54. |
[9] | 郭鹏,张巍.阿尔茨海默病患者睡眠障碍及其与认知障碍关系的研究[J]. 神经药理学报, 2018, 8(2): 61-61. |
[10] | 连腾宏,李少武,余秋瑾,等.阿尔茨海默病伴发嗅觉障碍的临床特点及静息态功能核磁共振成像的研究[J]. 神经药理学报, 2018, 8(2): 62-62. |
[11] | 金朝,郭鹏,左丽君,等.阿尔茨海默病患者视网膜纤维层厚度与临床症状关系[J]. 神经药理学报, 2018, 8(2): 69-69. |
[12] | 常福厚,白图雅,吕晓丽,胡玉霞,李君,林楠,周树宏.中蒙药对老年性痴呆治疗的研究进展[J]. 神经药理学报, 2018, 8(2): 73-73. |
[13] | 王同兴,韩 露,程肖蕊,周文霞,张永祥.基于神经内分泌免疫调节分子网络的防治阿尔茨海默病药物新靶点的探索性研究[J]. 神经药理学报, 2018, 8(2): 76-76. |
[14] | 林志彬.灵芝的抗衰老与抗阿尔茨海默病的药理研究进展[J]. 神经药理学报, 2018, 8(1): 9-15. |
[15] | 侯文书,张力.中药有效成分治疗阿尔茨海默病的作用靶点研究进展[J]. 神经药理学报, 2017, 7(5): 59-64. |
阅读次数 | ||||||
全文 |
|
|||||
摘要 |
|
|||||